quizartinib dihydrochloride
(kwih-ZAR-tih-nib dy-HY-droh-KLOR-ide)
A drug used with certain chemotherapy drugs and then alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia that has a certain mutation in the FLT3 gene. It is also being studied in the treatment of other types of cancer. Quizartinib dihydrochloride blocks FLT3 and other proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Vanflyta.